PDS Biotechnology Appoints Kamil Ali-Jackson, Esq. to Board of Directors

    NEXT STORY
    ORYZON Reports Financial Results and Corporate Update for 4th Quarter and Year Ended December 31, 2019
    PREV STORY
    Alimera Sciences Meets Revenue Milestone and Accesses Additional $2.5 Million Under Solar Debt Agreement
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Biodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In Patients

    BOULDER, Colo., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biodesix® chief technology officer, Dr. Heinrich ...

    author_avatar
    NASDAQ Market News

    TESARO Receives Positive CHMP Opinion for ZEJULA®

    ZUG, Switzerland, Sept. 15, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

    author_avatar
    NASDAQ Market News